Prostate-specific antigen and prostate-specific antigen derivatives as predictors of benign prostatic hyperplasia progression.
about
P21-Activated Kinase Inhibitors FRAX486 and IPA3: Inhibition of Prostate Stromal Cell Growth and Effects on Smooth Muscle Contraction in the Human ProstateA comprehensive approach toward novel serum biomarkers for benign prostatic hyperplasia: the MPSA Consortium.Glycoprotein analysis using protein microarrays and mass spectrometry.A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia.Inhibition of smooth muscle force generation by focal adhesion kinase inhibitors in the hyperplastic human prostate.Inhibition of prostate smooth muscle contraction and prostate stromal cell growth by the inhibitors of Rac, NSC23766 and EHT1864.Diagnosis and management of benign prostatic hyperplasia in primary care.2010 Update: Guidelines for the management of benign prostatic hyperplasia.Cynanchum wilfordii Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating 5α-Reductase and Androgen Receptor Activities in a Rat Model.Smooth muscle contraction and growth of stromal cells in the human prostate are both inhibited by the Src family kinase inhibitors, AZM475271 and PP2.Inhibition of smooth muscle contraction and ARF6 activity by the inhibitor for cytohesin GEFs, secinH3, in the human prostate.Inhibition of Adrenergic and Non-Adrenergic Smooth Muscle Contraction in the Human Prostate by the Phosphodiesterase 10-Selective Inhibitor TC-E 5005.Inhibition of Prostate Smooth Muscle Contraction by Inhibitors of Polo-Like Kinases.
P2860
Q28551296-92A6ABF9-2C31-4332-B273-E5D4E7FF9932Q33320106-0D5DA4BA-0317-4EF0-993E-BD60851F3E81Q33927735-0D20F71D-38FE-4640-8CA7-DAA4302DB80CQ37115315-5D81962C-D3CB-471B-9356-C439DEFE29FDQ39154967-F6FEC746-75DF-4266-A262-73FD4961309DQ40920822-81F4311E-7B7F-4F19-84E0-1E9BDF974755Q41986288-BE5D354D-EC01-4CD9-99B6-66E7155FE6DCQ42413446-C1DECBB7-EE72-4147-8EBB-14267451228CQ45339114-F5956B7A-4C7D-45B8-98B2-9F5019B76AD9Q47098074-5560FF8F-953B-4F4B-B8BD-270C0FE46D10Q50267774-7E0FEC0F-70A8-4D27-8192-71EE6B1A45B2Q51640625-E1A7A358-955E-4808-8020-7E7E2BA354ACQ55361601-5EF2796B-1581-4C52-8D3C-00B95AA23721
P2860
Prostate-specific antigen and prostate-specific antigen derivatives as predictors of benign prostatic hyperplasia progression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prostate-specific antigen and ...... tatic hyperplasia progression.
@en
Prostate-specific antigen and ...... tatic hyperplasia progression.
@nl
type
label
Prostate-specific antigen and ...... tatic hyperplasia progression.
@en
Prostate-specific antigen and ...... tatic hyperplasia progression.
@nl
prefLabel
Prostate-specific antigen and ...... tatic hyperplasia progression.
@en
Prostate-specific antigen and ...... tatic hyperplasia progression.
@nl
P1476
Prostate-specific antigen and ...... tatic hyperplasia progression.
@en
P2093
Jonathan M Levitt
Kevin M Slawin
P2888
P304
P356
10.1007/S11934-007-0072-Y
P577
2007-07-01T00:00:00Z